A model for metabolic activation of dialkylnitrosamines. Oxidative dealkylation of 2-(N-nitrosoalkylamino)acetonitriles by a flavin mimic in aqueous solution
Heilmittelchemische Studien In Der Heterocyclischen Reihe 35. Mitteilung. Über Sydnonimine. I. Herstellung und Eigenschaften von Sydnonimin-Salzen
作者:H. U. Daeniker、J. Druey
DOI:10.1002/hlca.19620450713
日期:——
The synthesis and properties of different types of sydnonimine salts have been investigated. The stability of these salts containing different types of acid components has been examined, and their behaviour towards bases and acids and on catalytic hydrogenation is described. The UV.- and NMR.-spectra of a number of these compounds are given and discussed.
Über eine neuartige Basen-katalysierte Umlagerung der Nitroso-Gruppe
作者:H. U. Daeniker
DOI:10.1002/hlca.19640470107
日期:——
By treatment with bases in methanolic solution N-substituted N-nitroso-amino-acetonitriles (I) undergo an internal rearrangement of the nitroso group to yield α-isonitroso-aminoacetonitriles (II). The structures of the rearrangement products are proved by their physico-chemical properties, by chemical degradation to known products, and by transformation into a number of derivatives. Similar compounds
A model for metabolic activation of dialkylnitrosamines. Oxidative dealkylation of N-nitroso-2-(alkylamino)acetonitrile by flavin mimic in aqueous solution
作者:Yumihiko Yano、Takeshi Yokoyama、Kitaro Yoshida
DOI:10.1016/s0040-4039(00)85149-7
日期:1986.1
Oxidation-active flavin mimic, benzo[1,2-g, 5,4-g′]dipteridine (BDP), is found to react with N-nitroso-2-(alkylamino)acetonitrile via oxidative dealkylation in aqueoussolution. From the kinetic investigations, the oxidation mechanism is proposed.
SYDNONIMINES-SPECIFIC DOPAMINE REUPTAKE INHIBITORS AND THEIR USE IN TREATING DOPAMINE RELATED DISORDERS
申请人:Chen Hao
公开号:US20090215839A1
公开(公告)日:2009-08-27
Derivatives of Sydnonimine and its analogues, which bind selectively to dopamine transporter (DAT) proteins are useful for treating and delaying the progression of disorders and illnesses that are alleviated by inhibiting dopamine reuptake.
SYDNONIMINES-SPECIFIC DOPAMINE REUPTAKE INHIBITORS AD THEIR USE IN TREATING DOPAMINE RELATED DISORDERS
申请人:Chen Hao
公开号:US20110288137A1
公开(公告)日:2011-11-24
Derivatives of Sydnonimine and its analogues, which bind selectively to dopamine transporter (DAT) proteins are useful for treating and delaying the progression of disorders and illnesses that are alleviated by inhibiting dopamine reuptake.